Additional Information
Book Details
Abstract
The detection of tumors in various organ systems remains one of the central applications of ultrasound. This issue of Ultrasound Clinics will consist of 10 articles under the title “Oncologic Ultrasound and will feature several articles on elastrography (a developing method for distinguishing tumors from normal tissue), as well as endoscopic ultrasound in oncology, ultrasound guidance in tumor ablation, and ultrasound guided biopsies. The editor, Vikram Dogra, who also serves as consulting editor of the series, has put together an issue that addresses the core clinical concerns of oncologic imaging for the radiologist specializing in ultrasound.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Oncologic Ultrasound\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| Contents | v | ||
| Ultrasound Clinics\r | viii | ||
| Preface | xi | ||
| Elastography | 1 | ||
| Key points | 1 | ||
| Introduction | 1 | ||
| The physics of elastography | 1 | ||
| Approaches to elastography | 3 | ||
| Quasistatic Elastography | 3 | ||
| Harmonic Elastography Based on Local Frequency Estimation | 5 | ||
| Transient Elastography Based on Arrival Time Estimation | 6 | ||
| The future of elastography | 7 | ||
| Viscoelasticity | 7 | ||
| Nonlinearity | 8 | ||
| References | 8 | ||
| Elastography of Thyroid Masses | 13 | ||
| Key points | 13 | ||
| Discussion of problem/clinical presentation | 13 | ||
| Imaging protocols | 13 | ||
| Imaging Findings | 13 | ||
| Quasi-static or strain elastography or sonoelastography | 13 | ||
| Acoustic radiation force imaging | 15 | ||
| Shear wave elastography | 15 | ||
| Pearls, pitfalls, and variants | 16 | ||
| What the referring physician needs to know | 19 | ||
| Summary | 22 | ||
| References | 22 | ||
| The Special Contribution of Contrast-Enhanced Ultrasound to Oncology | 25 | ||
| Key points | 25 | ||
| Preamble | 25 | ||
| CEUS: the procedure | 26 | ||
| The oncology population | 27 | ||
| The liver | 29 | ||
| The kidney | 34 | ||
| The pancreas | 35 | ||
| The gallbladder and biliary ducts | 36 | ||
| Other organs and tumors | 36 | ||
| Monitoring angiogenesis | 36 | ||
| Advantages of CEUS | 37 | ||
| Disadvantages of CEUS | 37 | ||
| Summary | 39 | ||
| References | 39 | ||
| Endoscopic Ultrasound in Oncology | 43 | ||
| Key points | 43 | ||
| Introduction | 43 | ||
| EUS equipment | 43 | ||
| EUS in GI oncology | 44 | ||
| Esophageal Cancer | 44 | ||
| Pancreatic Cancer | 45 | ||
| Rectal Cancer | 47 | ||
| Gastric Cancer | 47 | ||
| Liver Masses and Hepatocellular Carcinoma | 48 | ||
| Subepithelial Lesions in the Gastrointestinal Tract | 48 | ||
| EUS in non-GI oncology applications | 48 | ||
| Lung Cancer and Mediastinal Adenopathy (Lymphoma) | 48 | ||
| Renal Masses | 49 | ||
| EUS-based therapeutic interventions in oncology | 50 | ||
| Complications of EUS and EUS-FNA | 50 | ||
| Summary | 51 | ||
| References | 51 | ||
| Therapeutic Applications of Endoscopic Ultrasound | 53 | ||
| Key points | 53 | ||
| Introduction | 53 | ||
| CPN and Celiac Plexus Block | 53 | ||
| EUS-guided Brachytherapy | 54 | ||
| EUS-guided Fiducial Marker Placement | 55 | ||
| Ethanol Ablation | 56 | ||
| EUS-guided Delivery of Antitumor Agents | 57 | ||
| EUS-guided Bile Duct Access | 58 | ||
| EUS-guided Tumor Ablation | 59 | ||
| Pancreatic Pseudocyst and Pelvic Abscess Drainage with the Aid of EUS | 60 | ||
| EUS-guided pancreatic pseudocyst drainage | 60 | ||
| EUS-guided pelvic abscess drainage | 60 | ||
| Summary | 62 | ||
| References | 62 | ||
| Ultrasound Guidance in Tumor Ablation | 67 | ||
| Key points | 67 | ||
| Introduction | 67 | ||
| Principles of radiofrequency ablation | 68 | ||
| Principles of cryoablation | 68 | ||
| General selection criteria | 68 | ||
| Selection criteria for hepatic ablation | 70 | ||
| Selection criteria for renal ablation | 71 | ||
| Selection of imaging modalities | 71 | ||
| Sonoelastography and contrast-enhanced ultrasonography | 73 | ||
| Specifics of ultrasound-guided procedures | 73 | ||
| Alternative methods of ablation | 77 | ||
| Summary | 78 | ||
| References | 78 | ||
| Ultrasound-Guided Biopsy of the Prostate | 81 | ||
| Key points | 81 | ||
| Discussion of problem/clinical presentation | 81 | ||
| Preprocedural evaluation | 81 | ||
| Indications of TRUS-Guided Prostate Biopsy | 81 | ||
| Patient discomfort and anesthesia | 82 | ||
| Patient Preparation | 82 | ||
| Bowel cleansing | 82 | ||
| Antibiotic prophylaxis | 83 | ||
| Anticoagulant avoidance | 83 | ||
| Prebiopsy anesthesia | 83 | ||
| Anatomy | 84 | ||
| Sonographic Anatomy | 84 | ||
| Imaging features | 84 | ||
| Biopsy protocols | 84 | ||
| Technique of TRUS-Guided Prostate Biopsy | 84 | ||
| Systematic biopsy | 86 | ||
| Targeted biopsy | 87 | ||
| Follow-up TRUS-guided prostate biopsy | 87 | ||
| Saturation biopsy | 87 | ||
| Transperineal biopsy | 87 | ||
| Advanced Imaging Techniques | 88 | ||
| Transrectal contrast-enhanced ultrasound-guided biopsy | 88 | ||
| Elastography | 88 | ||
| MR imaging–assisted biopsies | 88 | ||
| Complications of TRUS-Guided Biopsy | 90 | ||
| Pearls, pitfalls, and variants | 90 | ||
| Pathology | 90 | ||
| What the referring physician needs to know | 91 | ||
| Summary | 91 | ||
| References | 91 | ||
| Prostate Cancer Biomarkers | 95 | ||
| Key points | 95 | ||
| Introduction | 95 | ||
| Biomarkers | 95 | ||
| PSA | 95 | ||
| [-2]proPSA and prostate health index | 96 | ||
| 4Kscore and Prostarix | 96 | ||
| PCA3 | 97 | ||
| TMPRSS2:ERG | 97 | ||
| Summary | 97 | ||
| References | 97 | ||
| Salivary Gland | 99 | ||
| Key points | 99 | ||
| Anatomy of the parotid space | 99 | ||
| Anatomy of the submandibular gland | 101 | ||
| Anatomy of the sublingual gland | 101 | ||
| Clinical presentation of a salivary gland tumor | 101 | ||
| The role of imaging | 101 | ||
| Sonographic technique | 102 | ||
| Salivary gland neoplastic disease | 102 | ||
| Benign tumors | 103 | ||
| Pleomorphic adenomas | 103 | ||
| Warthin tumor (cystadenolymphoma) | 104 | ||
| Oncocytoma | 105 | ||
| Other benign nonepithelial tumors | 105 | ||
| Malignant lesion | 105 | ||
| Mucoepidermoid carcinoma | 105 | ||
| Adenoid cystic carcinoma | 106 | ||
| Metastasis | 106 | ||
| Lymphoma | 107 | ||
| Carcinoma ex pleomorphic adenomas | 107 | ||
| Color flow assessment | 107 | ||
| Tumor mimics | 108 | ||
| Pitfalls | 109 | ||
| Interventional salivary gland ultrasound | 109 | ||
| New developments | 110 | ||
| What the referring clinician needs to know | 111 | ||
| Summary | 111 | ||
| References | 111 | ||
| Index | 115 |